| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Repare Therapeutics Inc (NASDAQ: RPTX)
RPTX Technical Analysis
4
| As on 9th Jun 2023 RPTX STOCK Price closed @ 12.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 13.79 & Strong Sell for SHORT-TERM with Stoploss of 16.57 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RPTXSTOCK Price
| Open | 12.88 | Change | Price | % |
| High | 13.67 | 1 Day | 0.10 | 0.84 |
| Low | 11.63 | 1 Week | 1.72 | 16.70 |
| Close | 12.02 | 1 Month | 2.76 | 29.81 |
| Volume | 137000 | 1 Year | -9.07 | -43.01 |
| 52 Week High 22.20 | 52 Week Low 8.45 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RPTX Daily Charts |
RPTX Intraday Charts |
Whats New @ Bazaartrend |
RPTX Free Analysis |
|
|
RPTX Important Levels Intraday
| RESISTANCE | 15.95 |
| RESISTANCE | 14.69 |
| RESISTANCE | 13.91 |
| RESISTANCE | 13.13 |
| SUPPORT | 10.91 |
| SUPPORT | 10.13 |
| SUPPORT | 9.35 |
| SUPPORT | 8.09 |
RPTX Forecast May 2024
| 4th UP Forecast | 28.44 |
| 3rd UP Forecast | 23.17 |
| 2nd UP Forecast | 19.92 |
| 1st UP Forecast | 16.66 |
| 1st DOWN Forecast | 7.38 |
| 2nd DOWN Forecast | 4.12 |
| 3rd DOWN Forecast | 0.87 |
| 4th DOWN Forecast | -4.4 |
RPTX Weekly Forecast
| 4th UP Forecast | 18.94 |
| 3rd UP Forecast | 16.72 |
| 2nd UP Forecast | 15.35 |
| 1st UP Forecast | 13.98 |
| 1st DOWN Forecast | 10.06 |
| 2nd DOWN Forecast | 8.69 |
| 3rd DOWN Forecast | 7.32 |
| 4th DOWN Forecast | 5.10 |
RPTX Forecast2024
| 4th UP Forecast | 42.16 |
| 3rd UP Forecast | 32.49 |
| 2nd UP Forecast | 26.52 |
| 1st UP Forecast | 20.54 |
| 1st DOWN Forecast | 3.5 |
| 2nd DOWN Forecast | -2.48 |
| 3rd DOWN Forecast | -8.45 |
| 4th DOWN Forecast | -18.12 |
Repare Therapeutics Inc ( NASDAQ USA Symbol : RPTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RPTX Business Profile
Repare Therapeutics Inc., a precision oncology company, discovers and develops novel therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small-molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, a proprietary drug discovery program for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montréal, Canada. Address: 7210 Frederick-Banting, Montreal, QC, Canada, H4S 2A1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service